Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02988713 · ClinicalTrials.gov registry record · NA
Study to Characterize Effects of Programming in SCS Patients Undergoing a Temporary Trial
A NA study of Chronic Pain, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 2
- Study locations
NCT02988713: Completed NA study of Chronic Pain, sponsored by Boston Scientific Corporation.
NCT02988713 is a NA study of Chronic Pain that has completed, run by Boston Scientific Corporation. The registered enrollment target is 35 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02988713, a NA study of Chronic Pain, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective, multi-center, non-randomized, exploratory, single-arm study characterize the effects of programming spinal cord stimulation (SCS) in patients undergoing a Boston Scientific (BSC) spinal cord stimulation (SCS) temporary trial
Primary Outcome
Number of participants reporting comfort level of stimulation sensation as "Very Comfortable" or "Slightly Comfortable"
Conditions Studied
Interventions
- DEVICE Programming
Study Locations (2)
California
- Pacific Pain Management, Inc. - Ventura
South Carolina
- PCPMG Clinical Research Unit, LLC - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2016-12-13 |
| Est. Completion | 2020-12-02 |
| Phase | NA |
What the finished NCT02988713 record still lists
NCT02988713 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Programming is the first listed.
NCT02988713 reports a single indexed study location in California, South Carolina.
Frequently Asked Questions
What is clinical trial NCT02988713 about?
NCT02988713 is a clinical study titled "Study to Characterize Effects of Programming in SCS Patients Undergoing a Temporary Trial". This is a prospective, multi-center, non-randomized, exploratory, single-arm study characterize the effects of programming spinal cord stimulation (SCS) in patients undergoing a Boston Scientific (BSC) spinal cord stimulation (SCS) temporary trial
What is the current status of trial NCT02988713?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2016-12-13. Estimated completion is 2020-12-02.
What conditions does trial NCT02988713 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT02988713?
The interventions under investigation include: Programming (DEVICE).
Who is sponsoring clinical trial NCT02988713?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02988713 being conducted?
This trial has 2 study locations across California, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02988713's enrollment target sits among peer trials
35 231st of 301 higher than 68 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI